The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Noninvasive Detection of Clinically Occult Lymph-Node Metastases in Prostate Cancer
Open accessAbstract
BACKGROUND: Accurate detection of lymph-node metastases in prostate cancer is an essential component of the approach to treatment. We investigated whether highly lymphotropic superparamagnetic nanoparticles, which gain access to lymph nodes by means of interstitial-lymphatic fluid transport, could be used in conjunction with high-resolution magnetic resonance imaging (MRI) to reveal small nodal metastases. METHODS: Eighty patients with presurgical clinical stage T1, T2, or T3 prostate cancer who underwent surgical lymph-node resection or biopsy were enrolled. All patients were examined by MRI before and 24 hours after the intravenous administration of lymphotropic superparamagnetic nanoparticles (2.6 mg of iron per kilogram of body weight). The imaging results were correlated with histopathological findings. RESULTS: Of the 334 lymph nodes that underwent resection or biopsy, 63 (18.9 percent) from 33 patients (41 percent) had histopathologically detected metastases. Of these 63 nodes, 45 (71.4 percent) did not fulfill the usual imaging criteria for malignancy. MRI with lymphotropic superparamagnetic nanoparticles correctly identified all patients with nodal metastases, and a node-by-node analysis had a significantly higher sensitivity than conventional MRI (90.5 percent vs. 35.4 percent, P<0.001) or nomograms. CONCLUSIONS: High-resolution MRI with magnetic nanoparticles allows the detection of small and otherwise undetectable lymph-node metastases in patients with prostate cancer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Significantly higher sensitivity for lymph node characterization in patients with prostate cancer, in which metastases detection with positron emission tomography (PET) is problematic, could be achieved by using ferumoxtran compared to non-contrast-enhanced MR imaging [160, 161].”
From Iron oxide nanoparticles: Diagnostic, therapeutic and theranostic applications (2019) · cites this paper as [161]
In the citing paper
“Significantly higher sensitivity for lymph node characterization in patients with prostate cancer, in which metastases detection with positron emission tomography (PET) is problematic, could be achieved by using ferumoxtran compared to non-contrast-enhanced MR imaging [160, 161].”
From Iron oxide nanoparticles: Diagnostic, therapeutic and theranostic applications (2019) · cites this paper as [160]
In the citing paper
“By using USPIO and contrast-enhanced MRI, micro-metastatic lymph nodes can be distinguished much more efficiently from healthy and inflammatory nodes [161].”
From Iron oxide nanoparticles: Diagnostic, therapeutic and theranostic applications (2019) · cites this paper as [161]
Citations
Cites
The Measurement of Observer Agreement for Categorical Data
Landis, J. R., & Koch, G. G. (1977) · Biometrics · doi:10.2307/2529310 · Cited by 81,148
Beneficial Effect of Carotid Endarterectomy in Symptomatic Patients with High-Grade Carotid Stenosis
(1991) · New England Journal of Medicine · doi:10.1056/nejm199108153250701 · Cited by 8,368
Stary, H. C., Chandler, A. B., Dinsmore, R. E., Fuster, V., Glagov, S. K., Insull, W., Rosenfeld, M. E., Schwartz, C. J., Wagner, W. D., & Wissler, R. W. (1995) · Circulation · doi:10.1161/01.cir.92.5.1355 · Cited by 3,506
Greenlee, R. T., Hill-Harmon, M. B., Murray, T., & Thun, M. J. (2001) · CA A Cancer Journal for Clinicians · doi:10.3322/canjclin.51.1.15 · Cited by 3,281
Lewin, M., Carlesso, N., Tung, C., Tang, X. S., Cory, D. G., Scadden, D. T., & Weissleder, R. (2000) · Nature Biotechnology · doi:10.1038/74464 · Cited by 1,716
Self-citationROC Methodology in Radiologic Imaging
Metz, C. E. (1986) · Investigative Radiology · doi:10.1097/00004424-198609000-00009 · Cited by 1,628
Bolla, M., González, D., Warde, P. R., Dubois, J. B., Mirimanoff, R., Storme, G. A., Bernier, J., Kuten, A., Sternberg, C. N., Gil, T., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199707313370502 · Cited by 1,547
Messing, E. M., Manola, J. B., Sarosdy, M., Wilding, G., Crawford, E. D., & Trump, D. L. (1999) · New England Journal of Medicine · doi:10.1056/nejm199912093412401 · Cited by 1,178
Magnetic relaxation switches capable of sensing molecular interactions
Pérez, J. M. S., Josephson, L., O'Loughlin, T., Högemann, D., & Weissleder, R. (2002) · Nature Biotechnology · doi:10.1038/nbt720 · Cited by 889
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 401–500 of 1,000
Souvatzoglou, M., Krause, B. J., Pürschel, A., Thamm, R., Schuster, T., Buck, A. K., Zimmermann, F. B., Molls, M., Schwaiger, M., & Geinitz, H. (2011) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2011.05.005 · Cited by 97
Lu, C., Bhatt, L. R., Jun, H. Y., Park, S., & Chai, K. Y. (2012) · Journal of Materials Chemistry · doi:10.1039/c2jm34327d · Cited by 97
Akın, O., & Hricak, H. (2007) · Radiologic Clinics of North America · doi:10.1016/j.rcl.2006.10.008 · Cited by 97
Utility of a New Bolus-injectable Nanoparticle for Clinical Cancer Staging
Harisinghani, M. G., Ross, R. W., Guimarães, A. R., & Weissleder, R. (2007) · Neoplasia · doi:10.1593/neo.07940 · Cited by 97
Self-citationEndometrial cancer: magnetic resonance imaging
Manfredi, R., Gui, B., Maresca, G., Fanfani, F., & Bonomo, L. (2005) · Abdominal Imaging · doi:10.1007/s00261-004-0298-9 · Cited by 97
Multimodality and nanoparticles in medical imaging
Huang, W.-Y., & Davis, J. J. (2011) · Dalton Transactions · doi:10.1039/c0dt01656j · Cited by 101
MRI of Bladder Cancer: Local and Nodal Staging
Caglič, I., Panebianco, V., Vargas, H. A., Bura, V., Woo, S., Pecoraro, M., Cipollari, S., Sala, E., & Barrett, T. (2020) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.27090 · Cited by 96
Briganti, A., Suardi, N. R., Capogrosso, P., Passoni, N. M., Freschi, M., Trapani, E. D., Andrea Gallina, A., Umberto Capitanio, A., Abdollah, F., Tutolo, M., et al. (2011) · The Prostate · doi:10.1002/pros.21420 · Cited by 96
Qiao, R., Liu, C., Liu, M., Hu, H., Liu, C., Hou, Y., Wu, K., Lin, Y., Liang, J., & Gao, M. (2015) · ACS Nano · doi:10.1021/nn507433p · Cited by 95
Commonly Used Imaging Techniques for Diagnosis and Staging
Barentsz, J. O., Takahashi, S., Oyen, W. J. G., Mus, R. D. M., Mulder, P. D., Reznek, R. H., Oudkerk, M., & Mali, W. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.5946 · Cited by 95
Self-citationNanomedicine as a non-invasive strategy for drug delivery across the blood brain barrier
Tam, V. H., Sosa, C. L., Liu, R., Yao, N., & Priestley, R. D. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.10.031 · Cited by 97
Nanotechnology: Future of Oncotherapy
Gharpure, K. M., Wu, S. Y., Li, C., Lopez‐Berestein, G., & Sood, A. K. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-1189 · Cited by 94
Emerging technology: applications of Raman spectroscopy for prostate cancer
Kast, R. E., Tucker, S. C., Killian, K., Trexler, M., Honn, K. V., & Auner, G. W. (2014) · Cancer and Metastasis Reviews · doi:10.1007/s10555-013-9489-6 · Cited by 94
Molecular diagnostics in transplantation
Naesens, M., & Sarwal, M. (2010) · Nature Reviews Nephrology · doi:10.1038/nrneph.2010.113 · Cited by 95
Abdollah, F., Briganti, A., Montorsi, F., Stenzl, A., Stief, C. G., TOMBAL, B. F., Poppel, H. V., & Touijer, K. A. (2014) · European Urology · doi:10.1016/j.eururo.2014.03.019 · Cited by 93
Iron Oxide Nanoparticles in Bioimaging – An Immune Perspective
Geppert, M., & Himly, M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.688927 · Cited by 95
Molecular Imaging of Innate Immune Cell Function in Transplant Rejection
Christen, T., Nahrendorf, M., Wildgruber, M., Świrski, F. K., Aïkawa, E., Waterman, P. R., Shimizu, K., Weissleder, R., & Libby, P. (2009) · Circulation · doi:10.1161/circulationaha.108.796888 · Cited by 93
Self-citationDiagnostic nanocarriers for sentinel lymph node imaging
Jain, R. D., Dandekar, P. P., & Patravale, V. B. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.05.010 · Cited by 92
Smart nanosystems: Bio-inspired technologies that interact with the host environment
Kwon, E. J., Lo, J. H.-J., & Bhatia, S. N. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1508522112 · Cited by 92
Relaxivity of Ferumoxytol at 1.5 T and 3.0 T
Knobloch, G., Colgan, T. J., Wiens, C. N., Wang, X., Schubert, T. B., Hernando, D., Sharma, S. D., & Reeder, S. B. (2017) · Investigative Radiology · doi:10.1097/rli.0000000000000434 · Cited by 92
Noninvasive imaging of pancreatic inflammation and its reversal in type 1 diabetes
Turvey, S. E. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25048 · Cited by 93
Ross, R. W., Zietman, A. L., Xie, W., Coen, J. J., Dahl, D. M., Shipley, W. U., Kaufman, D. S., Islam, T., Guimarães, A. R., Weissleder, R., et al. (2009) · Clinical Imaging · doi:10.1016/j.clinimag.2009.01.013 · Cited by 91
Self-citationYigit, M. V., Ghosh, S. K., Kumar, M., Petkova, V., Kavishwar, A., Moore, A. V., & Medarova, Z. O. (2012) · Oncogene · doi:10.1038/onc.2012.173 · Cited by 91
Application of magnetic nanoparticles in biomedicine
Pershina, A. G., Sazonov, A. E., & Васильевич, М. И. (2008) · Bulletin of Siberian Medicine · doi:10.20538/1682-0363-2008-2-70-78 · Cited by 91
Koh, D., George, C., Temple, L., Collins, D. J., Toomey, P., Raja, A., Bett, N., Farhat, S., Husband, J. E., & Brown, G. M. (2010) · American Journal of Roentgenology · doi:10.2214/ajr.08.1819 · Cited by 90
Harada, T., Tanigawa, N., Matsuki, M., Nohara, T., & Narabayashi, I. (2007) · European Journal of Radiology · doi:10.1016/j.ejrad.2007.02.010 · Cited by 90
Management of recurrent disease after radical prostatectomy
Bott, S. (2004) · Prostate Cancer and Prostatic Diseases · doi:10.1038/sj.pcan.4500732 · Cited by 90
Wang, L., Hricak, H., Kattan, M. W., Schwartz, L. H., Eberhardt, S. C., Chen, H.-N., & Scardino, P. T. (2006) · American Journal of Roentgenology · doi:10.2214/ajr.04.1682 · Cited by 90
“Clickable” Nanoparticles for Targeted Imaging
Sun, E. Y., Josephson, L., & Weissleder, R. (2006) · Molecular Imaging · doi:10.2310/7290.2006.00013 · Cited by 90
Self-citationInherent multifunctional inorganic nanomaterials for imaging-guided cancer therapy
Ju, Y., Dong, B., Yu, J. X., & Hou, Y. (2019) · Nano Today · doi:10.1016/j.nantod.2019.03.006 · Cited by 89
Thrall, J. H. (2004) · Radiology · doi:10.1148/radiol.2302031698 · Cited by 89
Sensitive, Noninvasive Detection of Lymph Node Metastases
Harisinghani, M. G., & Weissleder, R. (2004) · PLoS Medicine · doi:10.1371/journal.pmed.0010066 · Cited by 89
Self-citationLiu, S., Jia, B., Qiao, R., Yang, Z. H., Yu, Z., Liu, Z., Liu, K., Shi, J., Ouyang, H., Wang, F., et al. (2009) · Molecular Pharmaceutics · doi:10.1021/mp900143a · Cited by 89
Computed tomography evaluation of regional lymph node metastases in patients with biliary cancer
Noji, T., Kondo, S., Hirano, S., Tanaka, E., Suzuki, O., & Shichinohe, T. (2007) · British journal of surgery · doi:10.1002/bjs.5920 · Cited by 89
Wu, L., Cao, Y., Liao, C., Huang, J., & Gao, F. (2010) · European Journal of Radiology · doi:10.1016/j.ejrad.2009.11.027 · Cited by 88
Imaging diagnosis of metastatic breast cancer
Pesapane, F., Downey, K., Rotili, A., Cassano, E., & Koh, D. (2020) · Insights into Imaging · doi:10.1186/s13244-020-00885-4 · Cited by 88
Exploiting nanotechnology to target cancer
Sengupta, S., & Sasisekharan, R. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603707 · Cited by 88
Jeschke, S. W., Nambirajan, T., Leeb, K., Ziegerhofer, J., Sega, W., & Janetschek, G. (2005) · The Journal of Urology · doi:10.1097/01.ju.0000158159.16314.eb · Cited by 88
Bimodal magnetic–fluorescent probes for bioimaging
Jańczewski, D., Zhang, Y., Das, G. K., Yi, D. K., Padmanabhan, P., Bhakoo, K. K., Tan, T. T. Y., & Selvan, S. T. (2010) · Microscopy Research and Technique · doi:10.1002/jemt.20912 · Cited by 88
PET/CT Imaging and Radioimmunotherapy of Prostate Cancer
Bouchelouche, K., Tagawa, S. T., Goldsmith, S. J., Türkbey, B., Capala, J., & Choyke, P. L. (2010) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2010.08.005 · Cited by 88
MR Lymphangiography: Imaging Strategies to Optimize the Imaging of Lymph Nodes with Ferumoxtran-10
Harisinghani, M. G., Dixon, W. T., Saksena, M. A., Brachtel, E. F., Blezek, D. J., Dhawale, P. J., Torabi, M., & Hahn, P. F. (2004) · Radiographics · doi:10.1148/rg.243035190 · Cited by 88
Self-citationLymph node imaging: Basic principles
Luciani, A., Itti, E., Rahmouni, A., Meignan, M. A., & Clémеnt, O. (2006) · European Journal of Radiology · doi:10.1016/j.ejrad.2005.12.038 · Cited by 88
Ost, P., Troyer, B. D., Fonteyne, V., Oosterlinck, W., & Meerleer, G. D. (2010) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2010.04.039 · Cited by 87
The Roles of PET and PET/CT in the Diagnosis and Management of Prostate Cancer
Takahashi, N., Inoue, T., Lee, J., Yamaguchi, T., & Shizukuishi, K. (2007) · Oncology · doi:10.1159/000112946 · Cited by 87
Nanoparticles for Cancer Therapy Using Magnetic Forces
Tietze, R., Lyer, S., Dürr, S., & Alexiou, C. (2012) · Nanomedicine · doi:10.2217/nnm.12.10 · Cited by 86
Organ-specific toxicity of magnetic iron oxide-based nanoparticles
Chrishtop, V. V., Mironov, V. A., Prilepskii, A. Y., Nikonorova, V. G., & Vinogradov, V. V. (2021) · Nanotoxicology · doi:10.1080/17435390.2020.1842934 · Cited by 86
Nanoparticle therapeutics for prostate cancer treatment
Sanna, V., & Sechi, M. (2012) · Maturitas · doi:10.1016/j.maturitas.2012.01.016 · Cited by 86
Surface‐Functionalized Nanoparticle Library Yields Probes for Apoptotic Cells
Schellenberger, E. A., Reynolds, F., Weissleder, R., & Josephson, L. (2004) · ChemBioChem · doi:10.1002/cbic.200300713 · Cited by 86
Self-citationImaging the lymphatic system: possibilities and clinical applications
Clémеnt, O., & Luciani, A. (2004) · European Radiology · doi:10.1007/s00330-004-2265-9 · Cited by 85
Song, Y., Huang, Z., Xu, J., Ren, D., Wang, Y., Zheng, X., Shen, Y., Wang, L., Gao, H., Hou, J., et al. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2013.12.038 · Cited by 85
Staging of carcinoma of the uterine cervix and endometrium
Koyama, T., Tamai, K., & Togashi, K. (2007) · European Radiology · doi:10.1007/s00330-006-0555-0 · Cited by 85
Highly monodisperse water-dispersable iron oxide nanoparticles for biomedical applications
Hofmann, A., Thierbach, S., Semisch, A., Hartwig, A., Taupitz, M., Rühl, E., & Graf, C. M. (2010) · Journal of Materials Chemistry · doi:10.1039/c0jm01169j · Cited by 85
Potential of nano-phytochemicals in cervical cancer therapy
Yadav, N., Parveen, S., & Banerjee, M. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.01.035 · Cited by 86
A Fluorescent Nanosensor for Apoptotic Cells
Quinti, L., Weissleder, R., & Tung, C. (2006) · Nano Letters · doi:10.1021/nl0524694 · Cited by 84
Self-citationMolecular imaging of prostate cancer with 18F-fluorodeoxyglucose PET
Jadvar, H. (2009) · Nature Reviews Urology · doi:10.1038/nrurol.2009.81 · Cited by 84
Kundra, V., Silverman, P. M., Matin, S. F., & Choi, H. (2007) · American Journal of Roentgenology · doi:10.2214/ajr.07.2011 · Cited by 84
Designer adenoviruses for nanomedicine and nanodiagnostics
Singh, R. N., & Kostarelos, K. (2009) · Trends in biotechnology · doi:10.1016/j.tibtech.2009.01.003 · Cited by 84
Nanoparticle therapeutics for prostate cancer treatment
Sanna, V., & Sechi, M. (2012) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2012.05.009 · Cited by 84
Morikawa, L. K. K., & Roach, M. (2011) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2010.11.074 · Cited by 83
Value of diffusion-weighted imaging to detect small malignant pelvic lymph nodes at 3 T
Roy, C., Bierry, G., Matau, A., Bazille, G., & Pasquali, R. (2010) · European Radiology · doi:10.1007/s00330-010-1736-4 · Cited by 83
Multiparametric MRI - local staging of prostate cancer and beyond
Caglič, I., Kovač, V., & Barrett, T. (2019) · Radiology and Oncology · doi:10.2478/raon-2019-0021 · Cited by 83
Burton, J. B., Johnson, M., Sato, M., Koh, S. B. S., Mulholland, D. J., Stout, D., Chatziioannou, A. F., Phelps, M. E., Wu, H., & Wu, L. (2008) · Nature Medicine · doi:10.1038/nm.1727 · Cited by 82
Analysis of 300 dentofacial deformities in Hong Kong.
Samman, N., Tong, A. C., Cheung, D. L., & Tideman, H. (1992) · PubMed · Cited by 82
chapter 5 Synthesis, Properties and Biomedical Applications of Magnetic Nanoparticles
Tartaj, P., Morales, M. P., Veintemillas-Verdaguer, S., González-Carreño, T., & Serna, C. J. (2006) · Handbook of magnetic materials · doi:10.1016/s1567-2719(05)16005-3 · Cited by 82
Design of superparamagnetic nanoparticles for magnetic particle imaging (MPI)
Du, Y., Lai, P., Leung, C., & Pong, P. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140918682 · Cited by 81
The top 100 cited articles in urology: An update
Nason, G. J., Tareen, F., & Mortell, A. E. (2013) · Canadian Urological Association Journal · doi:10.5489/cuaj.189 · Cited by 82
Mazzucchelli, S., Colombo, M., Palma, C. D., Salvadè, A., Verderio, P., Coghi, M. D., Clementi, E., Tortora, P., Corsi, F., & Prosperi, D. (2010) · ACS Nano · doi:10.1021/nn101307r · Cited by 83
Leary, S. P., Liu, C. Y., & Apuzzo, M. L. J. (2006) · Neurosurgery · doi:10.1227/01.neu.0000216793.45952.ed · Cited by 81
Polymeric micelles for enhanced lymphatic drug delivery to treat metastatic tumors
Qin, L., Zhang, F., Lu, X., Wei, X., Wang, J., Fang, X., Si, D., Wang, Y., Zhang, C., Yang, R., et al. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.07.005 · Cited by 80
Design and Application of Magnetic-Based Theranostic Nanoparticle Systems
Wadajkar, A. S., Menon, J. U., Kadapure, T. D., Tran, R. T., Yang, J. Y., & Nguyen, K. T. (2013) · Recent Patents on Biomedical Engineering · doi:10.2174/1874764711306010007 · Cited by 80
Johnson, L., Pinder, S. E., & Douek, M. (2012) · Histopathology · doi:10.1111/his.12019 · Cited by 80
Combes, G. F., Vučković, A., Bakulić, M. P., Antoine, R., Bonačić‐Koutecký, V., & Trajković, K. (2021) · Cancers · doi:10.3390/cancers13164206 · Cited by 81
Facile Preparation of a Hybrid Nanoprobe for Triple‐Modality Optical/PET/MR Imaging
Park, J. C., Yu, M. K., An, G. I., Park, S., Oh, J., Kim, H. J., Kim, J., Wang, E. K., Hong, I., Ha, Y. S., et al. (2010) · Small · doi:10.1002/smll.201001418 · Cited by 81
Beuzeboc, P., Cornud, F., Eschwège, P., Gaschignard, N., Grosclaude, P., Hennequin, C., Maingon, P., Molinié, V., Mongiat-Artus, P., Moreau, J.-L., et al. (2007) · The French Journal of Urology · doi:10.1016/s1166-7087(07)74785-1 · Cited by 80
Kulkarni, T., Gollins, S., Maw, A., Hobson, P., Byrne, R., & Widdowson, D. J. (2008) · Colorectal Disease · doi:10.1111/j.1463-1318.2007.01451.x · Cited by 80
Computer technology in detection and staging of prostate carcinoma: A review
Yanong Zhu, A., Williams, S. M., & Reyer Zwiggelaar, A. (2005) · Medical Image Analysis · doi:10.1016/j.media.2005.06.003 · Cited by 79
Wu, E. X., Tang, H., & Jensen, J. H. (2004) · NMR in Biomedicine · doi:10.1002/nbm.923 · Cited by 79
Semiconducting polymer dots with bright narrow-band emission at 800 nm for biological applications
Chen, D., Wu, I.-C., Liu, Z., Tang, Y., Chen, H., Yu, J., Wu, C., & Chiu, D. T. (2017) · Chemical Science · doi:10.1039/c7sc00441a · Cited by 78
Kim, D., Lee, N., Park, Y. I., & Hyeon, T. (2016) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.6b00654 · Cited by 78
Advances in clinical MRI technology
Harisinghani, M. G., O’Shea, A., & Weissleder, R. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aba2591 · Cited by 78
Self-citationCross-sectional imaging of nodal metastases in the abdomen and pelvis
Koh, D., Hughes, M., & Husband, J. E. (2006) · Abdominal Imaging · doi:10.1007/s00261-006-9022-2 · Cited by 78
Otto, S. D., Lee, L., Buhr, H. J., Frericks, B. B., Höcht, S., & Kroesen, A. J. (2009) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-009-0870-2 · Cited by 78
Motomura, K., Ishitobi, M., Komoike, Y., Koyama, H., Noguchi, A., Sumino, H., Kumatani, Y., Inaji, H., Horinouchi, T., & Nakanishi, K. (2011) · Annals of Surgical Oncology · doi:10.1245/s10434-011-1710-7 · Cited by 78
Grootendorst, D. J., Jose, J., Fratila, R. M., Visscher, M., Velders, A. H., ten Haken, B., van Leeuwen, T. G. J. M., Steenbergen, W., Manohar, S., & Ruers, T. J. M. (2012) · Contrast Media & Molecular Imaging · doi:10.1002/cmmi.1498 · Cited by 78
Multiparametric Monitoring of Tumor Response to Chemotherapy by Noninvasive Imaging
Medarova, Z. O., Rashkovetsky, L. G., Pantazopoulos, P., & Moore, A. V. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2001 · Cited by 78
Nanoparticles for dendritic cell-based immunotherapy
Tran, T. H., Tran, T. T. P., Nguyen, H. T., Phung, C. D., Jeong, J., Stenzel, M. H., Jin, S. G., Yong, C. S., Truong, D. H., & Kim, J. O. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.03.029 · Cited by 81
Imaging applications of nanotechnology in cancer
Gunasekera, U. A., Pankhurst, Q. A., & Douek, M. (2009) · Targeted Oncology · doi:10.1007/s11523-009-0118-9 · Cited by 77
Comparison of 11C-choline-PET/CT and whole body-MRI for staging of prostate cancer
Pfannenberg, A. C., Rieger, A., Aschoff, P., Müller, M., Paulsen, F., Anastasiadis, A. G., Claussen, C., Bares, R., Schlemmer, H., & Eschmann, S. M. (2007) · Nuklearmedizin - NuclearMedicine · doi:10.1160/nukmed-0075 · Cited by 77
Fiandra, L., Mazzucchelli, S., Palma, C. D., Colombo, M., Allevi, R., Sommaruga, S., Clementi, E., Bellini, M., Prosperi, D., & Corsi, F. (2013) · ACS Nano · doi:10.1021/nn4018922 · Cited by 79
Nanobiomaterials: State of the Art and Future Trends
Yang, L., Zhang, L., & Webster, T. J. (2011) · Advanced Engineering Materials · doi:10.1002/adem.201080140 · Cited by 77
Molecular Imaging in Tracking Tumor-Specific Cytotoxic T Lymphocytes (CTLs)
Liu, Z., & Li, Z. (2014) · Theranostics · doi:10.7150/thno.9268 · Cited by 78
Contemporary management of penile squamous cell carcinoma
Kroon, B. K., Horenblas, S., & Nieweg, O. E. (2004) · Journal of Surgical Oncology · doi:10.1002/jso.20170 · Cited by 77
Manninger, S., Muldoon, L. L., Nesbit, G. M., Murillo, T. P., Jacobs, P. M., & Neuwelt, E. A. (2005) · PubMed Central · Cited by 77
van Rijk, M. C., Teertstra, H. J., Peterse, J. L., Nieweg, O. E., Olmos, R. A. V., Hoefnagel, C. A., & Kroon, B. B. R. (2006) · Annals of Surgical Oncology · doi:10.1245/s10434-006-9106-9 · Cited by 77
Land, R., Herod, J., Moskovic, E. C., King, M., Sohaib, S. A., Trott, P. A., Nasiri, N., Shepherd, J. H., BRIDGES, J. E., Ind, T. E. J., et al. (2006) · International Journal of Gynecological Cancer · doi:10.1111/j.1525-1438.2006.00340.x · Cited by 76
BIOMEDICAL APPLICATIONS OF MAGNETIC NANOPARTICLES
Wu, A., OU, P., & Zeng, L. (2010) · NANO · doi:10.1142/s1793292010002165 · Cited by 75
Jereczek‐Fossa, B. A., & Orecchia, R. (2007) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2007.04.013 · Cited by 75
Nanoparticles for the Optical Imaging of Tumor selectin
Funovics, M. A., Montet, X., Reynolds, F., Weissleder, R., & Josephson, L. (2005) · Neoplasia · doi:10.1593/neo.05352 · Cited by 75
Self-citationPrediction of anti-cancer nanotherapy efficacy by imaging
Miller, M. A., Arlauckas, S., & Weissleder, R. (2017) · Nanotheranostics · doi:10.7150/ntno.20564 · Cited by 74
Self-citationComplement opsonization of nanoparticles: Differences between humans and preclinical species
Li, Y., Wang, G., Griffin, L. R., Banda, N. K., Saba, L. M., Groman, E. V., Scheinman, R. I., Moghimi, S. M., & Simberg, D. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.08.048 · Cited by 74
Metadata
- Authors
- Harisinghani, M. G., Barentsz, J., Hahn, P. F., Deserno, W. M., Tabatabaei, S., van de Kaa, C. H., de la Rosette, J., & Weissleder, R.
- Affiliations
- Harvard University (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2003-06-19
- Volume
- 348
- Issue
- 25
- Pages
- 2491-2499
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2116810900
- Cited by
- 1,971
- References
- 42
- Citations by year
- 2026: 13 · 2025: 15 · 2024: 34 · 2023: 42 · 2022: 54 · 2021: 49 · 2020: 59 · 2019: 50 · 2018: 66 · 2017: 82 · 2016: 83 · 2015: 94 · 2014: 95 · 2013: 120 · 2012: 129
- FWCI
- 81.09
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Funders
- National Institutes of Health (5r01ca059649-07)
- National Cancer Institute (R01-CA59649)
- Topics
- Health Sciences › Medicine › Urology › Prostate Cancer Diagnosis and Treatment
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › MRI in cancer diagnosis
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Medical Imaging Techniques and Applications
- Keywords
- prostate cancer, lymph node metastasis, superparamagnetic iron oxide nanoparticles, magnetic resonance imaging, non-invasive detection, lymphatic drainage, diagnostic sensitivity
- MeSH terms
- Aged, Biopsy, Contrast Media, Ferric Compounds, Humans, Image Processing, Computer-Assisted, Lymph Nodes, Lymphatic Metastasis, Magnetic Resonance Imaging, Magnetics, Male, Middle Aged, Neoplasm Staging, Particle Size, Prospective Studies, Prostatic Neoplasms, Sensitivity and Specificity, Nanotechnology
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
